A Digital Lifeline: Combining Blood Biomarkers and Cognitive Learning Curves to Predict Decline
A new study investigates whether a multi-day learning curve (MDLC), derived from remote digital cognitive tests over one week, can add prognostic value to the established plasma biomarker p-tau217 for predicting cognitive decline in older adults. The research involved 183 cognitively unimpaired participants who underwent both digital testing and blood analysis, with their cognitive trajectories tracked for 2.5 years.
Continue reading to unlock the full analysis, deeper implications, and why this study may matter for your field.
Unlock Full Briefing — 50% Off with Coupon: ERWMCWYU
Full version includes the complete summary, study significance, and direct link to the original source.
Stay curious. Stay informed — with Science Briefing.
This is a preview briefing. Upgrade to access the full version.
